These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11755441)

  • 61. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.
    Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC
    Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The crisis of resistant pathogens in respiratory tract infections--use of pharmacodynamic principles.
    Palavecino EL
    Am J Manag Care; 2001 Jun; 7(6 Suppl):S170-7. PubMed ID: 11424585
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study.
    Thornsberry C; Sahm DF
    Chemotherapy; 2000; 46 Suppl 1():15-23. PubMed ID: 10810209
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998.
    Zhanel GG; Karlowsky JA; Low DE; Hoban DJ
    J Antimicrob Chemother; 2000 May; 45(5):655-62. PubMed ID: 10797089
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical implications of resistance in the management of respiratory tract infections.
    Garau J
    Can Respir J; 1999; 6 Suppl A():23A-6A. PubMed ID: 10202229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Results from the Solithromycin International Surveillance Program (2014).
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3662-8. PubMed ID: 27044551
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
    Nishioka K; Ogihara H; Ohno I; Shirato K
    Jpn J Antibiot; 1997 Sep; 50(9):768-75. PubMed ID: 9394237
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections].
    Zientara M; Rudy M; Nowakowska M; Martirosian G
    Med Dosw Mikrobiol; 2006; 58(3):239-45. PubMed ID: 17340999
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
    Senok A; Al-Zarouni M; Al-Najjar J; Nublusi A; Panigrahi D
    J Infect Dev Ctries; 2007 Dec; 1(3):296-302. PubMed ID: 19734608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN; Fritsche TR; Sader HS; Stilwell MG
    Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
    Powell M; McVey D; Kassim MH; Chen HY; Williams JD
    J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.
    Sahm DF; Jones ME; Hickey ML; Diakun DR; Mani SV; Thornsberry C
    J Antimicrob Chemother; 2000 Apr; 45(4):457-66. PubMed ID: 10747822
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
    Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 2000 Feb; 45(2):191-203. PubMed ID: 10660501
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program.
    Sokol W
    Am J Med; 2001 Dec; 111 Suppl 9A():19S-24S. PubMed ID: 11755439
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
    Owens RC; Tessier P; Nightingale CH; Ambrose PG; Quintiliani R; Nicolau DP
    Int J Antimicrob Agents; 2001 Jun; 17(6):483-9. PubMed ID: 11397619
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe.
    Debbia EA; Shito GC; Pesce A; Marchese A
    Infection; 1999; 27 Suppl 2():S9-12. PubMed ID: 10885819
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Macrolide resistance: an increasing concern for treatment failure in children.
    Jacobs MR; Johnson CE
    Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S131-8. PubMed ID: 14566999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.